33 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
.C.Auditors
Smythe LLP (“Smythe”), of Vancouver, Canada, (Public Company Accounting Oversight Board (“PCAOB”) Firm ID No. 995) serves as the Company’s … , ultimately, we have oversight as the sponsor and must act accordingly.
If any of our clinical trial sites terminate for any reason, we may experience
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
.C.Auditors
Smythe LLP (“Smythe”), of Vancouver, Canada, (Public Company Accounting Oversight Board (“PCAOB”) Firm ID No. 995) serves as the Company’s … , ultimately, we have oversight as the sponsor and must act accordingly.
If any of our clinical trial sites terminate for any reason, we may experience
424B5
XRTX
XORTX Therapeutics Inc
29 Nov 23
Prospectus supplement for primary offering
9:57pm
Accountants of British Columbia and under all relevant U.S. professional and regulatory standards, including Public Company Accounting Oversight Board Rule 3520
424B3
XRTX
XORTX Therapeutics Inc
14 Aug 23
Prospectus supplement
4:42pm
Accountants of British Columbia and under all relevant U.S. professional and regulatory standards, including Public Company Accounting Oversight Board
424B3
i5tbcd5hi g69
14 Aug 23
Prospectus supplement
4:40pm
POS AM
067p3 qw7
4 Aug 23
Prospectus update (post-effective amendment)
4:08pm
POS AM
7119zs cii
4 Aug 23
Prospectus update (post-effective amendment)
4:05pm
6-K
EX-99.2
3g5f7x49k4y98
30 May 23
Notice of Annual & Special Meeting of Shareholders
7:00am
6-K
EX-99.1
44o 6ggq6kp
3 Apr 23
Consolidated Financial Statements
6:05am
6-K
EX-99.3
4fc3zunx2agfpx2oav
3 Apr 23
Consolidated Financial Statements
6:05am
424B4
gl0ea8bd9
5 Oct 22
Prospectus supplement with pricing info
5:24pm
POS AM
gat6o8vkdl zttbuww
29 Sep 22
Prospectus update (post-effective amendment)
9:49pm
F-1/A
94m0hw fk
21 Sep 22
Registration statement (foreign) (amended)
4:20pm
F-1
ur0d iv0k4hm2rl
8 Sep 22
Registration statement (foreign)
1:02pm
DRS
72svv o9dgg825zl69fa
15 Aug 22
Draft registration statement
12:00am
6-K
EX-99.2
9d8pherm2m3u 67hi6
30 Jun 22
Notice of Annual & Special Meeting of Shareholders
6:00am
20-F
uxk7ywljl269f0mb6
3 May 22
Annual report (foreign)
5:29pm